Satellos Bioscience, Inc. (MSLE)
6.66
+0.31
(+4.88%)
USD |
NASDAQ |
Nov 06, 10:31
Satellos Bioscience EPS Diluted (Quarterly) : -0.5625 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5625 |
| March 31, 2026 | -0.5299 |
| December 31, 2025 | -0.4724 |
| September 30, 2025 | -0.4175 |
| June 30, 2025 | -0.393 |
| March 31, 2025 | -0.037 |
| December 31, 2024 | -0.316 |
| September 30, 2024 | -0.0587 |
| June 30, 2024 | -0.0391 |
| March 31, 2024 | -0.5458 |
| December 31, 2023 | -0.0425 |
| September 30, 2023 | -0.0236 |
| June 30, 2023 | -0.0392 |
| March 31, 2023 | -0.0294 |
| December 31, 2022 | -0.0894 |
| September 30, 2022 | -0.0416 |
| June 30, 2022 | -0.0531 |
| March 31, 2022 | -0.0506 |
| December 31, 2021 | -0.0608 |
| September 30, 2021 | -0.3403 |
| June 30, 2021 | -9.076 |
| March 31, 2021 | -8.908 |
| December 31, 2020 | -4.361 |
| September 30, 2020 | -2.868 |
| June 30, 2020 | -0.03 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0635 |
| December 31, 2019 | -0.067 |
| September 30, 2019 | -0.0598 |
| June 30, 2019 | -0.0526 |
| March 31, 2019 | -0.0564 |
| December 31, 2018 | -0.0441 |
| September 30, 2018 | -0.0756 |
| June 30, 2018 | -0.1549 |
| March 31, 2018 | -0.078 |
| December 31, 2017 | -0.0398 |
| September 30, 2017 | -0.0584 |
| June 30, 2017 | -0.0588 |
| March 31, 2017 | -0.0682 |
| December 31, 2016 | -0.0405 |
| September 30, 2016 | -0.0379 |
| June 30, 2016 | -0.0355 |
| March 31, 2016 | -0.1456 |
| December 31, 2015 | -0.1498 |
| September 30, 2015 | -0.03 |
| June 30, 2015 | -0.1626 |
| March 31, 2015 | -0.0482 |
| December 31, 2014 | 0.0326 |
| September 30, 2014 | -0.0673 |
| June 30, 2014 | -0.3668 |
| March 31, 2014 | -0.1813 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | -1.112 |
| Psyence Biomedical Ltd. | -3.178 |
| Aurinia Pharmaceuticals, Inc. | 0.2345 |
| enGene Therapeutics, Inc. | -0.4661 |
| Medicus Pharma Ltd. | -0.1524 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.72M |
| Total Expenses (Quarterly) | 11.72M |
| Enterprise Value | 70.49M |
| Earnings Yield | -29.76% |
| Normalized Earnings Yield | -29.76 |